178 related articles for article (PubMed ID: 27370408)
1. Abnormalities in biomarkers of mineral and bone metabolism in kidney donors.
Kasiske BL; Kumar R; Kimmel PL; Pesavento TE; Kalil RS; Kraus ES; Rabb H; Posselt AM; Anderson-Haag TL; Steffes MW; Israni AK; Snyder JJ; Singh RJ; Weir MR
Kidney Int; 2016 Oct; 90(4):861-8. PubMed ID: 27370408
[TBL] [Abstract][Full Text] [Related]
2. Low serum levels of intact osteocalcin in patients with congestive heart failure.
Schleithoff SS; Zittermann A; Stüttgen B; Tenderich G; Berthold HK; Körfer R; Stehle P
J Bone Miner Metab; 2003; 21(4):247-52. PubMed ID: 12811631
[TBL] [Abstract][Full Text] [Related]
3. Relationship between plasma levels of sclerostin, calcium-phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients.
Pietrzyk B; Wyskida K; Ficek J; Kolonko A; Ficek R; Więcek A; Olszanecka-Glinianowicz M; Chudek J
Int Urol Nephrol; 2019 Mar; 51(3):519-526. PubMed ID: 30584645
[TBL] [Abstract][Full Text] [Related]
4. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; Di Nero G
J Pediatr; 1993 Jan; 122(1):37-45. PubMed ID: 8419613
[TBL] [Abstract][Full Text] [Related]
6. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
7. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
Katagiri M; Fukunaga M; Ohtawa T; Harada T
World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
[TBL] [Abstract][Full Text] [Related]
8. A cross-sectional study on biochemical parameters of bone turnover and vitamin d metabolites in healthy dutch children and young adults.
van der Sluis IM; Hop WC; van Leeuwen JP; Pols HA; de Muinck Keizer-Schrama SM
Horm Res; 2002; 57(5-6):170-9. PubMed ID: 12053089
[TBL] [Abstract][Full Text] [Related]
9. Changes in bone mass and serum markers of bone metabolism after parathyroidectomy.
Thorsen K; Kristoffersson AO; Lorentzon RP
Surgery; 1997 Nov; 122(5):882-7. PubMed ID: 9369887
[TBL] [Abstract][Full Text] [Related]
10. Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation.
Young A; Hodsman AB; Boudville N; Geddes C; Gill J; Goltzman D; Jassal SV; Klarenbach S; Knoll G; Muirhead N; Prasad GV; Treleaven D; Garg AX;
Am J Kidney Dis; 2012 Jun; 59(6):761-9. PubMed ID: 22093959
[TBL] [Abstract][Full Text] [Related]
11. Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation.
Schreiber PW; Bischoff-Ferrari HA; Boggian K; Bonani M; van Delden C; Enriquez N; Fehr T; Garzoni C; Hirsch HH; Hirzel C; Manuel O; Meylan P; Saleh L; Weisser M; Mueller NJ;
PLoS One; 2018; 13(1):e0191167. PubMed ID: 29338022
[TBL] [Abstract][Full Text] [Related]
12. The adaptation and relationship of FGF-23 to changes in mineral metabolism in Graves' disease.
Park SE; Cho MA; Kim SH; Rhee Y; Kang ES; Ahn CW; Cha BS; Lee EJ; Kim KR; Lee HC; Lim SK
Clin Endocrinol (Oxf); 2007 Jun; 66(6):854-8. PubMed ID: 17437520
[TBL] [Abstract][Full Text] [Related]
13. Assessment of tubular reabsorption of phosphate as a surrogate marker for phosphate regulation in chronic kidney disease.
Hong YA; Lim JH; Kim MY; Kim Y; Yang KS; Chung BH; Chung S; Choi BS; Yang CW; Kim YS; Chang YS; Park CW
Clin Exp Nephrol; 2015 Apr; 19(2):208-15. PubMed ID: 24682550
[TBL] [Abstract][Full Text] [Related]
14. Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men.
Gram J; Junker P; Nielsen HK; Bollerslev J
Bone; 1998 Sep; 23(3):297-302. PubMed ID: 9737353
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.
Dhayat NA; Ackermann D; Pruijm M; Ponte B; Ehret G; Guessous I; Leichtle AB; Paccaud F; Mohaupt M; Fiedler GM; Devuyst O; Pechère-Bertschi A; Burnier M; Martin PY; Bochud M; Vogt B; Fuster DG
Kidney Int; 2016 Sep; 90(3):648-57. PubMed ID: 27370409
[TBL] [Abstract][Full Text] [Related]
16. Correlations of new markers of bone formation and resorption in kidney transplant recipients.
Małyszko J; Wołczyński S; Małyszko JS; Konstantynowicz J; Kaczmarski M; Myśliwiec M
Transplant Proc; 2003 Jun; 35(4):1351-4. PubMed ID: 12826157
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D status and markers of bone turnover in Caucasian and South Asian postmenopausal women living in the UK.
Lowe NM; Mitra SR; Foster PC; Bhojani I; McCann JF
Br J Nutr; 2010 Jun; 103(12):1706-10. PubMed ID: 20102676
[TBL] [Abstract][Full Text] [Related]
18. Altered bone and mineral metabolism in patients receiving imatinib mesylate.
Berman E; Nicolaides M; Maki RG; Fleisher M; Chanel S; Scheu K; Wilson BA; Heller G; Sauter NP
N Engl J Med; 2006 May; 354(19):2006-13. PubMed ID: 16687713
[TBL] [Abstract][Full Text] [Related]
19. The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure.
Tsuchida T; Ishimura E; Miki T; Matsumoto N; Naka H; Jono S; Inaba M; Nishizawa Y
Osteoporos Int; 2005 Feb; 16(2):172-9. PubMed ID: 15164161
[TBL] [Abstract][Full Text] [Related]
20. Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease.
Valdemarsson S; Lindergård B; Tibblin S; Bergenfelz A
J Intern Med; 1998 Feb; 243(2):115-22. PubMed ID: 9566639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]